Medical scientist Prof Ram Shankar Upadhayaya suggests Alzheimer's is reversible by identifying and addressing its root ...

A new Alzheimer’s drug, lecanemab, may slow disease progression and offer patients up to four extra years of stable health.

In 2025, researchers created a stable version called diAcCA, and early lab results are promising. The compound improved ...

The degenerative brain disease that has besieged the National Football League for two decades with a billion-dollar lawsuit, ...

Alzheimer’s is a brain disorder that leads to memory loss and other mental problems. It is marked by two major changes in the ...

The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

The Alzheimer’s Association held its international conference in Toronto. The conference unveiled new research about ...

These tau tangles damage the brain, disrupting how neurons work and eventually leading to cell death. Early in Alzheimer’s, ...

As her memory faded from Alzheimer’s disease in her late 50s, Tammy Maida began to lose track of her life. Car keys, ...

In the early stages of Alzheimer’s disease, people may have trouble following conversations, repeat themselves, or struggle ...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...